Aytu Property Plant And Equipment Net vs Cash Analysis

AYTU Stock  USD 1.61  0.01  0.62%   
Aytu BioScience financial indicator trend analysis is way more than just evaluating Aytu BioScience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aytu BioScience is a good investment. Please check the relationship between Aytu BioScience Property Plant And Equipment Net and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Property Plant And Equipment Net vs Cash

Property Plant And Equipment Net vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aytu BioScience Property Plant And Equipment Net account and Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between Aytu BioScience's Property Plant And Equipment Net and Cash is 0.68. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Cash in the same time period over historical financial statements of Aytu BioScience, assuming nothing else is changed. The correlation between historical values of Aytu BioScience's Property Plant And Equipment Net and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Aytu BioScience are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Property Plant And Equipment Net i.e., Aytu BioScience's Property Plant And Equipment Net and Cash go up and down completely randomly.

Correlation Coefficient

0.68
Relationship DirectionPositive 
Relationship StrengthSignificant

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Cash

Cash refers to the most liquid asset of Aytu BioScience, which is listed under current asset account on Aytu BioScience balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Aytu BioScience customers. The amounts must be unrestricted with restricted cash listed in a different Aytu BioScience account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Aytu BioScience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aytu BioScience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.At this time, Aytu BioScience's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 39.82 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (377.02) in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit52.3M66.6M54.6M57.3M
Total Revenue96.7M107.4M81.0M85.1M

Aytu BioScience fundamental ratios Correlations

0.790.570.940.920.86-0.56-0.720.970.910.970.910.470.760.860.950.910.980.67-0.430.61-0.43-0.260.830.52-0.8
0.790.360.740.750.78-0.42-0.580.830.740.830.740.220.570.680.730.760.740.69-0.70.39-0.7-0.350.690.43-0.79
0.570.360.70.230.450.0-0.950.580.330.40.330.860.810.880.770.610.67-0.04-0.350.94-0.35-0.570.760.79-0.66
0.940.740.70.760.88-0.27-0.830.910.730.890.730.640.740.910.980.970.940.65-0.390.65-0.39-0.530.940.65-0.74
0.920.750.230.760.78-0.74-0.410.890.960.950.960.130.540.610.740.760.870.74-0.350.36-0.350.060.60.22-0.64
0.860.780.450.880.78-0.21-0.590.860.680.90.680.240.510.70.820.960.790.73-0.30.45-0.3-0.50.90.3-0.61
-0.56-0.420.0-0.27-0.74-0.210.13-0.55-0.83-0.56-0.830.07-0.47-0.3-0.34-0.19-0.56-0.270.3-0.240.3-0.56-0.04-0.010.51
-0.72-0.58-0.95-0.83-0.41-0.590.13-0.72-0.5-0.59-0.5-0.86-0.9-0.97-0.89-0.75-0.8-0.170.49-0.880.490.61-0.84-0.830.83
0.970.830.580.910.890.86-0.55-0.720.910.960.910.420.750.840.920.880.960.61-0.440.65-0.44-0.270.840.46-0.8
0.910.740.330.730.960.68-0.83-0.50.910.921.00.210.680.670.760.690.90.6-0.410.49-0.410.110.570.3-0.74
0.970.830.40.890.950.9-0.56-0.590.960.920.920.270.640.740.870.90.920.76-0.390.47-0.39-0.220.790.35-0.73
0.910.740.330.730.960.68-0.83-0.50.911.00.920.210.680.670.760.680.890.6-0.420.49-0.420.110.570.3-0.74
0.470.220.860.640.130.240.07-0.860.420.210.270.210.690.790.690.50.580.03-0.280.7-0.28-0.540.60.9-0.51
0.760.570.810.740.540.51-0.47-0.90.750.680.640.680.690.920.850.640.840.13-0.50.87-0.5-0.330.670.69-0.91
0.860.680.880.910.610.7-0.3-0.970.840.670.740.670.790.920.960.840.910.34-0.520.85-0.52-0.510.870.8-0.88
0.950.730.770.980.740.82-0.34-0.890.920.760.870.760.690.850.960.930.960.54-0.440.75-0.45-0.50.920.7-0.83
0.910.760.610.970.760.96-0.19-0.750.880.690.90.680.50.640.840.930.870.7-0.340.56-0.34-0.570.950.53-0.69
0.980.740.670.940.870.79-0.56-0.80.960.90.920.890.580.840.910.960.870.56-0.440.72-0.44-0.260.820.59-0.82
0.670.69-0.040.650.740.73-0.27-0.170.610.60.760.60.030.130.340.540.70.56-0.3-0.1-0.3-0.20.520.21-0.3
-0.43-0.7-0.35-0.39-0.35-0.30.30.49-0.44-0.41-0.39-0.42-0.28-0.5-0.52-0.44-0.34-0.44-0.3-0.391.00.16-0.32-0.590.67
0.610.390.940.650.360.45-0.24-0.880.650.490.470.490.70.870.850.750.560.72-0.1-0.39-0.39-0.340.690.64-0.72
-0.43-0.7-0.35-0.39-0.35-0.30.30.49-0.44-0.41-0.39-0.42-0.28-0.5-0.52-0.45-0.34-0.44-0.31.0-0.390.16-0.32-0.60.67
-0.26-0.35-0.57-0.530.06-0.5-0.560.61-0.270.11-0.220.11-0.54-0.33-0.51-0.5-0.57-0.26-0.20.16-0.340.16-0.68-0.480.34
0.830.690.760.940.60.9-0.04-0.840.840.570.790.570.60.670.870.920.950.820.52-0.320.69-0.32-0.680.59-0.67
0.520.430.790.650.220.3-0.01-0.830.460.30.350.30.90.690.80.70.530.590.21-0.590.64-0.6-0.480.59-0.6
-0.8-0.79-0.66-0.74-0.64-0.610.510.83-0.8-0.74-0.73-0.74-0.51-0.91-0.88-0.83-0.69-0.82-0.30.67-0.720.670.34-0.67-0.6
Click cells to compare fundamentals

Aytu BioScience Account Relationship Matchups

Aytu BioScience fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets152.8M265.7M137.6M136.5M118.1M124.0M
Other Current Liab14.9M7.4M49.5M55.5M47.5M49.9M
Total Current Liabilities28.3M109.4M64.4M69.0M62.2M65.3M
Total Stockholder Equity95.0M137.6M46.1M39.4M27.7M24.5M
Property Plant And Equipment Net892.6K8.7M6.3M3.9M1.5M1.4M
Net Debt(46.1M)(21.3M)(1.2M)(6.6M)(4.9M)(5.1M)
Retained Earnings(120.0M)(178.3M)(288.5M)(304.1M)(320.0M)(304.0M)
Accounts Payable11.8M19.3M11.0M13.5M10.4M5.4M
Cash48.1M49.6M19.4M23.0M20.0M12.0M
Non Current Assets Total77.9M160.4M77.7M63.6M56.2M31.3M
Cash And Short Term Investments48.1M49.6M19.4M23.0M20.0M12.1M
Common Stock Shares Outstanding226.0K837.3K1.5M3.3M5.5M5.8M
Liabilities And Stockholders Equity152.8M265.7M137.6M136.5M118.1M124.0M
Non Current Liabilities Total29.5M18.7M27.1M28.1M28.2M29.6M
Other Stockholder Equity215.0M315.9M331.4M343.5M347.7M365.1M
Total Liab57.8M128.1M91.5M97.1M90.4M94.9M
Property Plant And Equipment Gross1.2M8.7M6.3M3.9M3.6M3.8M
Total Current Assets75.0M105.2M59.9M72.8M61.9M65.0M
Common Stock Total Equity179.01.8K12.6K3K2.7K2.6K
Other Current Assets5.7M1.0M8.0M8.9M5.6M5.9M
Common Stock12.6K3K4K1K900.0855.0
Net Tangible Assets34.7M(13.7M)(24.5M)(19.6M)(17.7M)(16.8M)
Non Currrent Assets Other33.0K465K766K792K2.2M2.3M
Intangible Assets48.9M85.5M70.6M59.0M52.5M35.8M
Property Plant Equipment258.5K8.7M6.3M3.9M4.4M4.7M
Other Liab28.8M15.9M12.8M13.4M15.4M12.2M
Other Assets33.0K465K766K792K910.8K956.3K
Net Receivables5.2M28.2M21.7M28.9M23.6M24.8M
Inventory10.0M16.3M10.8M12.0M12.6M6.6M
Non Current Liabilities Other18.3M15.9M12.8M7.0M4.5M4.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.